基于电子健康记录队列的肝细胞癌风险详细种族/民族差异
该研究利用多机构电子健康记录队列(2000-2016/2017年,共4,248,553名成人)链接癌症登记数据,按17个详细种族/民族类别分析肝细胞癌(HCC)风险的性别特异性差异。结果显示越南裔美国人女性和男性HCC风险最高(女性HR 5.5, 95%CI 2.3-13.2;男性HR 5.4, 95%CI 3.1-9.6),多种其他种族/民族风险也高于非西班牙裔白人。探索性分析表明,在EHR记录的肝硬化背景下差异减弱,但无肝硬化时差异持续存在。
要点
- 越南裔美国人女性和男性HCC风险最高,女性HR 5.5(95%CI 2.3-13.2),男性HR 5.4(95%CI 3.1-9.6)。
- 多个种族/民族(如夏威夷原住民、华裔、韩裔、黑人、西班牙裔等)HCC风险高于非西班牙裔白人。
- 无EHR记录肝硬化时种族差异持续,提示筛查、诊断和诊疗差异。
核心结论
- 详细种族/民族分类揭示了HCC风险差异,越南裔美国人风险最高。
- 无EHR记录肝硬化时差异持续,提示筛查和治疗协调方面的差异。
研究设计与样本
- 多机构电子健康记录(EHR)队列研究,链接Sutter Health、Kaiser Permanente Hawai'i和San Francisco Health Network的成人患者数据(2000-2016或2017年)与基于人群的癌症登记数据。
- 共纳入4,248,553名患者,其中2,916例发生HCC;采用性别分层Cox回归分析。
主要发现
- 越南裔美国人女性HCC风险HR 5.5(95%CI 2.3-13.2),男性HR 5.4(95%CI 3.1-9.6),均以非西班牙裔白人为参照。
- 两性中,夏威夷原住民、华裔或韩裔美国人、其他单一亚洲种族或多个亚洲种族、黑人或西班牙裔的HCC风险均高于非西班牙裔白人。
- 菲律宾裔和日本裔美国人女性及男性、美国印第安人或阿拉斯加原住民、多种种族/民族者的风险也较高。
- 探索性分析显示,在EHR记录的肝硬化背景下,两性的种族/民族差异减弱;无肝硬化时差异持续存在。
临床怎么用
- 临床应关注越南裔美国人等高危人群的HCC筛查,尤其在无肝硬化记录时。
- 详细种族/民族数据有助于识别HCC风险差异,指导筛查和治疗协调。
局限性
- EHR数据可能未完全捕捉所有肝硬化病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We assessed sex-specific disparities in hepatocellular carcinoma (HCC) risk according to detailed race/ethnicity with a multi-institutional, electronic health record (EHR)-based cohort. METHODS: We linked an EHR-based cohort of adult patients at Sutter Health, Kaiser Permanente Hawai'i, and San Francisco Health Network from 2000 to 2016 or 2017 to population-based cancer registry data for incident HCC. Race and ethnicity data were operationalized into 17 detailed categories. We used sex-stratified Cox regression to assess racial/ethnic disparities in HCC. A secondary analysis explored cirrhosis-stratified disparities, with cirrhosis being defined as the occurrence of one or more International Classification of Diseases, Ninth or Tenth Revision codes indicating cirrhosis or complications thereof. RESULTS: Among 4,248,553 patients, 2916 developed HCC. Vietnamese American females (hazard ratio, 5.5; 95% confidence interval, 2.3-13.2) and males (hazard ratio, 5.4; 95% confidence interval, 3.1-9.6) had the highest HCC risk compared with their non-Hispanic White counterparts. For both sexes, those who were Native Hawaiian, Chinese or Korean American, had another single Asian ethnicity or multiple Asian ethnicities, or were Black or Hispanic had greater HCC risk than non-Hispanic White patients. Filipino and Japanese American females and males and those who were American Indian or Alaska Native or had multiple races or ethnicities also had greater risk. Exploratory analyses showed that, for both sexes, racial/ethnic disparities were mitigated within the context of EHR-documented cirrhosis but not without. CONCLUSIONS: Our innovative use of EHR data on race and ethnicity advances disparities research methodology, yielding findings on HCC disparities not apparent with broad categories. More persistent racial/ethnic disparities among those without EHR-documented cirrhosis suggest racial and ethnic differences in coordinated hepatitis screening and treatment, cirrhosis recognition and documentation, or health care delivery and thus inform efforts to reduce HCC disparities.
引用
- DeRouen MC, Thompson CA, Canchola AJ, et al. Detailed Racial/Ethnic Disparities in Hepatocellular Carcinoma Risk With an Electronic Health Record-Based Cohort. Clin Gastroenterol Hepatol. 2026. PMID: 42551816. doi:10.1016/j.cgh.2026.07.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。